JAMA Publishes COVID Vaccine Study the CDC Shelved

2026-06-25

Silence came first, not science. A large safety analysis run inside the CDC’s own databases flagged patterns that critics say should have triggered a transparent public review, yet the agency declined to publish the findings in a scientific journal.

Now JAMA has done what the CDC did not. In a peer-reviewed article built on the same vaccine safety surveillance system and similar signal-detection methods, researchers report that COVID vaccination still shows net benefit, even while acknowledging statistical associations that fuel concern. The work leans on established pharmacoepidemiology tools such as proportional reporting ratios and background incidence comparisons, pushing disputed numbers into the open instead of leaving them as internal memoranda.

The uncomfortable truth is that the journal, not the regulator, is cleaning up the communication mess. By subjecting the analysis to external review, JAMA forces a public argument over risk ratios, confidence intervals, and adverse event coding, rather than a political argument over who buried what. Trust in vaccination rarely collapses because of one hazard estimate; it erodes when agencies appear to curate evidence in-house while others do the publishing for them.

Recommendations